Primary Gastric Lymphoma: Clinicopathological Profile

Introduction Gastrointestinal tract (GIT) is the most common site of involvement of extranodal non-Hodgkin’s lymphoma (NHL). There is regional variation in anatomical distribution of extranodal NHL, stomach being the most common site followed by small intestine. Primary gastric lymphoma (PGL) predominantly involves the antrum and corpus of the stomach. It arises from mucosa-associated lymphoid tissue (MALT) and is of B-cell lineage and often associated with Helicobacter pylori infection. Primary gastric lymphoma often presents with nonspecific symptoms. The present study was undertaken to ascertain the clinicopathological characteristics of PGL at a tertiary care center in South India. Materials and methods It is a retrospective study from 2006 to 2016. Patient’s data were obtained from institutional medical records. The histopathology slides were reviewed. The relevant immunohistochemistry (IHC) markers done were leukocyte common antigen (LCA), CD3, CD20, CD79a, CD10, Bcl-2, Bcl-6, CD5, Cyclin D1, CD138, and Ki-67. Correlating with the immunoprofile, further subtyping was done. Results A total of 405 patients of NHL were seen during the study period, out of which 43 patients were PGL. There were 32 males and 11 females, with M:F of 2.9:1. The mean age at diagnosis was 58 years. Abdominal pain and new-onset dyspepsia were the commonly observed presenting symptoms. The common site of involvement was antrum (20). Diffuse large B-cell lymphoma (DLBCL) was the most common histological subtype. Helicobacter pylori infection was seen in 18 (41%) patients. Majority of the patients were in stages II and III. Conclusion In our study, the initial presentation of PGL was with nonspecific symptoms like abdominal pain and new-onset dyspepsia. High degree of suspicion of such symptoms and biopsy of all suspicious lesions is essential for early detection. Diffuse large B-cell lymphoma was the most common histological subtype seen in our study. How to cite this article: Malipatel R, Patil M, Rout P, Correa M, Devarbhavi H. Primary Gastric Lymphoma: Clinicopathological Profile. Euroasian J Hepato-Gastroenterol 2018;8(1):6-10.


INTRODUCTION
Gastrointestinal tract is the most common site of involvement of extranodal NHL, stomach being the most common site of involvement , which accounts for less than 5% of primary gastric neoplasms. [1][2][3][4] The involvement of stomach by lymphomas can be primary or secondary as a part of systemic lymphomas. The primary GIT lymphomas are defined as those in which involvement of the alimentary tract predominates or those with symptoms of GIT involvement on presentation. 5,6 The diagnosis of PGL is often delayed due to nonspecific initial symptoms like vague abdominal pain and new-onset 7 EJOHG St. John's Medical College, Bengaluru, Karnataka, India, from 2006 to 2016 (10 years). Patients' data were collected from the institutional medical records. Patients presenting with GI symptoms or predominant tumor(s) in the GI tract were included as PGL based on Lewin et al definition. 5 All patients underwent upper GI endoscopy (esophagogastroduodenoscopy) and gastric biopsy except one where laparotomy was done. The biopsies were processed in 10% formalin. Hematoxylin and eosin staining (H&E) was done on paraffin-embedded sections. The presence of H. pylori in the adjacent mucosa was noted. Immunohistochemistry was carried out manually on poly L-lysine-coated slides and controls run were satisfactory. Heat-induced antigen retrieval was done by pressure cooking the sections kept in Trisethylenediaminetetraacetic acid buffer. Avidin-Biotin peroxidase technique was used. The relevant IHC markers done were LCA, CD3, CD20, CD79a, CD10, Bcl-2, Bcl-6, CD5, Cyclin D1, CD138, and Ki-67. Correlating with the immunoprofile, further subtyping was done.
In all patients, physical examination, indirect laryngoscopy, complete blood count, liver function tests, lactate dehydrogenase, bone marrow examination, Chest X-ray, and computed tomography scan of the chest, abdomen, and pelvis were done for staging. Patients with systemic lymphomas involving the stomach were excluded from the study.

RESULTS
During the study period between 2006 and 2016, total 405 patients of NHL were seen, out of which 43 patients were PGL, constituting 10.6% of all NHL. There were 32 males and 11 females, with M:F of 2.9:1. The mean age at diagnosis was 58 years.
Abdominal pain and new-onset dyspepsia were the common presenting symptoms as shown in Table 1. The staging at the time of diagnosis was as shown in Table 2. The various sites of involvement were antrum (20), body (12), diffuse lesions (9), and fundus (2). The endoscopic appearances of PGL were as shown in Figure 1 (12), and erosions (2). The frequencies of various histological subtypes of PGL are listed in Table 3 and Figures 2 to 4. Helicobacter pylori infection was seen in 18 (41%) patients.

DISCUSSION
Gastrointestinal tract is the most common site of involvement for extranodal lymphoma, with stomach being the commonest. In our study, PGL constituted 10.6% of all NHL. The normal gastric mucosa is devoid of lymphatic tissue. 1 The lymphoid tissue appears in the stomach in response to chronic inflammation induced by H. pylori infection. Diffuse large B-cell lymphoma was the commonest histologic type seen in our study, which was similar to other studies from India and other parts of the world. 7,9,10 Follicular lymphoma of the stomach is rare. In our study, there was one case of follicular lymphoma that presented with obstructive symptoms and required laparotomy.
As observed in other studies, PGL in our study was seen in elderly people, predominantly in males. 7,11,12 Like in other studies the common presenting complaints were abdominal pain, new-onset dyspepsia, features of gastric outlet obstruction, anemia due to GI blood loss, jaundice, and dysphagia. [13][14][15] None of the patients had B constitutional

CONCLUSION
Primary gastric lymphomas present with initial nonspecific symptoms leading to delay in diagnosis. Hence, it is important to detect them at the earliest. Further studies on genetic and molecular profiling are necessary for understanding the pathogenetic mechanisms involved and for therapeutic and prognostic implications in different subtypes of PGL.